{"id":"https://openalex.org/W2602276296","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19537","title":"Interim analysis of a phase II trial of nab-paclitaxel in patients with very advanced relapsed/refractory multiple myeloma (RR-MM).","display_name":"Interim analysis of a phase II trial of nab-paclitaxel in patients with very advanced relapsed/refractory multiple myeloma (RR-MM).","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2602276296","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19537","mag":"2602276296"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.e19537","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19537","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19537","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051399808","display_name":"Allison Claire Rosenthal","orcid":"https://orcid.org/0000-0002-8915-3163","observed_orcids":["https://orcid.org/0000-0002-8915-3163"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Claire Rosenthal","raw_affiliation_strings":["Mayo Clinic Arizona, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, Phoenix, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003015868","display_name":"Rafa\u00ebl Fonseca","orcid":"https://orcid.org/0000-0002-5938-3769","observed_orcids":["https://orcid.org/0000-0002-5938-3769"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rafael Fonseca","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058598134","display_name":"Joseph R Mikhael","orcid":"https://orcid.org/0000-0001-9670-2864","observed_orcids":["https://orcid.org/0000-0001-9670-2864"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Mikhael","raw_affiliation_strings":["Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109667106","display_name":"A. Keith Stewart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Keith Stewart","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018647199","display_name":"Angela Mayo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Mayo","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007028620","display_name":"Marta Chesi","orcid":"https://orcid.org/0000-0002-4024-8225","observed_orcids":["https://orcid.org/0000-0002-4024-8225"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marta Chesi","raw_affiliation_strings":["Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038693643","display_name":"Heidi Kosiorek","orcid":"https://orcid.org/0000-0002-4651-9516","observed_orcids":["https://orcid.org/0000-0002-4651-9516"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi Kosiorek","raw_affiliation_strings":["Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004436275","display_name":"Peter Leif Bergsagel","orcid":"https://orcid.org/0000-0003-1523-7388","observed_orcids":["https://orcid.org/0000-0003-1523-7388"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Leif Bergsagel","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"e19537","last_page":"e19537"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9929999709129333},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9629999995231628},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.7429999709129333},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5210000276565552},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9470000267028809},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7879999876022339},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.44200000166893005},{"id":"https://openalex.org/keywords/free-light-chains","display_name":"free light chains","score":0.5709999799728394},{"id":"https://openalex.org/keywords/monoclonal-spike","display_name":"monoclonal spike","score":0.7379999756813049},{"id":"https://openalex.org/keywords/heavily-pretreated-patients","display_name":"heavily pretreated patients","score":0.734000027179718},{"id":"https://openalex.org/keywords/interim-analysis","display_name":"interim analysis","score":0.4099999964237213},{"id":"https://openalex.org/keywords/bortezomib-refractory-disease","display_name":"bortezomib-refractory disease","score":0.6499999761581421},{"id":"https://openalex.org/keywords/lenalidomide-refractory-disease","display_name":"lenalidomide-refractory disease","score":0.9300000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9108340740203857},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6301727294921875},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.5684314966201782},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.552920937538147},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5320438146591187},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.523790717124939},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5072564482688904},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.49258357286453247},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.4867077171802521},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.46744024753570557},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.4578359127044678},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.4506915509700775},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.44966378808021545},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4451088309288025},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.41546618938446045},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3907471299171448},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22662395238876343},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.21785417199134827},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.e19537","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19537","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19537","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2275346870","https://openalex.org/W2587039704","https://openalex.org/W2767317717","https://openalex.org/W2623834745","https://openalex.org/W2078027075","https://openalex.org/W2766470239","https://openalex.org/W2600193862","https://openalex.org/W2713571791","https://openalex.org/W2115298175","https://openalex.org/W2201882325"],"abstract_inverted_index":{"e19537":[0],"Background:":[1],"Nab-paclitaxel":[2,334],"(Abraxane)":[3],"has":[4],"demonstrated":[5],"anti-tumor":[6],"activity":[7],"in":[8,25,160,168,303,315,325,338],"a":[9,19,221,250],"murine":[10],"model":[11],"of":[12,18,41,119,133,174,211,298,341],"MM.":[13],"We":[14],"report":[15],"the":[16,292,342],"results":[17,319],"single":[20],"arm":[21],"phase":[22],"II":[23],"trial":[24,345],"RR-MM":[26],"patients":[27,114,153,181,248],"(pts).":[28],"Methods:":[29],"Eligibility":[30],"criteria":[31],"were:":[32],"\u2265":[33,37,57,60,63,77,251],"18yo,":[34],"M":[35,164],"spike":[36,165],"1g/dL,":[38],">":[39,49],"200mg":[40],"monoclonal":[42,316],"protein/24":[43],"hr":[44],"UPEP,":[45],"or":[46,215],"serum":[47,161],"FLC":[48,54,162],"10mg/dL":[50],"and":[51,90,97,124,139,149,163,190,235,243,279,310],"abnormal":[52],"kappa/lambda":[53],"ratio;":[55],"ANC":[56],"500/mm\u00b3,":[58],"platelets":[59],"25000/mm\u00b3,":[61],"Hb":[62],"6":[64,169,186],"g/dL,":[65],"Bili":[66],"\u2264":[67,71,75],"2.5x":[68],"ULN,":[69,73],"AST/ALT":[70],"5x":[72],"creatinine":[74],"3mg/dL;":[76],"3":[78,253],"prior":[79,135,155],"therapies;":[80,136],"negative":[81],"pregnancy":[82],"test.":[83],"Treatment":[84],"consisted":[85],"of:":[86],"100mg/m2":[87],"nab-paclitaxel":[88,288],"IV":[89],"dexamethasone":[91],"20mg":[92],"on":[93,194],"days":[94],"1,":[95,277,284],"8,":[96],"15":[98],"(28d":[99],"cycle)":[100],"for":[101],"up":[102,177],"to":[103,142,207,263,322],"12":[104],"cycles.":[105],"The":[106],"primary":[107],"endpoint":[108],"was":[109,166,231],"response":[110,223],"rate.":[111],"Results:":[112],"Thirteen":[113],"were":[115,126,129,140,237],"enrolled":[116],"(median":[117],"age":[118],"70":[120],"years;":[121],"range":[122,137],"46-81)":[123],"10":[125,152],"male.":[127],"Pts":[128],"heavily":[130],"pretreated":[131],"(average":[132],"7.6":[134],"3-12)":[138],"refractory":[141],"bortezomib":[143],"(100%),":[144,146],"lenalidomide":[145],"pomalidomide":[147],"(77%),":[148],"carfilzomib":[150],"(84.6%).":[151],"had":[154,213,306],"SCT.":[156],"A":[157],"quantifiable":[158],"decline":[159],"seen":[167],"patients.":[170],"With":[171],"2.3":[172],"months":[173,239,245],"median":[175],"follow":[176],"(range":[178,199],"0.7-13.2),":[179],"11":[180],"progressed.":[182],"At":[183],"interim":[184],"analysis,":[185],"pts":[187,192,202,212],"are":[188,320],"alive":[189],"no":[191],"remain":[193],"treatment.":[195],"Median":[196],"cycles:":[197],"2":[198],"1-6).":[200],"9":[201],"(69.2%)":[203],"discontinued":[204],"treatment":[205],"due":[206,262],"disease":[208,309],"progression.":[209],"46%":[210],"SD":[214],"better":[216],"with":[217],"one":[218],"pt":[219],"achieving":[220],"confirmed":[222],"(PR":[224],"[cycle":[225],"1],":[226],"VGPR":[227],"[cycles":[228],"2-5]).":[229],"PFS":[230],"1.61":[232],"months.":[233],"OS":[234],"TTP":[236],"3.08":[238],"(95%":[240],"CI":[241],"1.67-NR)":[242],"1.67":[244],"respectively.":[246],"Seven":[247],"experienced":[249],"grade":[252],"AE":[254],"at":[255],"least":[256],"partially":[257],"related,":[258],"including":[259],"1":[260],"death":[261],"sepsis.":[264],"Grade":[265],"4":[266],"toxicities":[267],"included:":[268],"neutropenia":[269,281],"(n":[270,275,282],"=":[271,276,283],"2,":[272],"15.4%),":[273],"thrombocytopenia":[274],"7.7%),":[278],"febrile":[280],"7.7%).":[285],"Conclusions:":[286],"While":[287],"did":[289],"not":[290],"reach":[291],"prespecified":[293],"endpoint,":[294],"it":[295],"showed":[296],"evidence":[297],"anti-MM":[299],"activity.":[300],"Patients":[301],"treated":[302],"this":[304],"protocol":[305],"very":[307],"advanced":[308,327],"yet":[311],"some":[312],"displayed":[313],"reductions":[314],"proteins.":[317],"These":[318],"similar":[321],"comparable":[323],"studies":[324],"fairly":[326],"populations":[328],"such":[329],"as":[330],"other":[331],"tubulin":[332],"inhibitors.":[333],"should":[335],"be":[336],"tested":[337],"earlier":[339],"phases":[340],"disease.":[343],"Clinical":[344],"information:":[346],"NCT01646762.":[347]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}